Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma.
作者信息
Oh Joo Hyun, Sinn Dong Hyun
机构信息
Division of Gastroenterology, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Division of Gastroenterology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
出版信息
J Liver Cancer. 2024 Sep;24(2):126-128. doi: 10.17998/jlc.2024.08.08. Epub 2024 Aug 16.
Abstract
摘要
相似文献
1
Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma.探讨肝切除术作为多结节BCLC-A期肝细胞癌一线治疗选择的作用。
J Liver Cancer. 2024 Sep;24(2):126-128. doi: 10.17998/jlc.2024.08.08. Epub 2024 Aug 16.
2
Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm.手术切除治疗大肝癌和巴塞罗那分期 C 期肝癌以外的肝癌：系统综述与提出的治疗方案算法。
Langenbecks Arch Surg. 2023 Apr 12;408(1):144. doi: 10.1007/s00423-023-02881-w.
3
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?超出巴塞罗那临床肝癌分期（BCLC）标准的肝细胞癌肝切除术：多结节病变、门静脉高压和门静脉系统侵犯真的是禁忌证吗？
J Gastrointest Oncol. 2022 Dec;13(6):3123-3134. doi: 10.21037/jgo-22-833.
4
Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinoma.多结节巴塞罗那临床肝癌B期肝细胞癌肝切除术后的结局
Oncol Lett. 2018 Nov;16(5):6383-6392. doi: 10.3892/ol.2018.9420. Epub 2018 Sep 7.
5
Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective.多灶性肝细胞癌：一篇从介入放射科医生角度评估治疗选择的叙述性综述
Ann Palliat Med. 2023 Nov;12(6):1244-1259. doi: 10.21037/apm-23-294. Epub 2023 Aug 9.
6
Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.中期（巴塞罗那临床肝癌分期B期）多发性肝细胞癌肝切除的选择标准。
Surgery. 2016 Nov;160(5):1227-1235. doi: 10.1016/j.surg.2016.05.023. Epub 2016 Jul 7.
7
Treatment of Hepatocellular Carcinoma.肝细胞癌的治疗
Dig Dis. 2016;34(5):597-602. doi: 10.1159/000445275. Epub 2016 Jun 22.
8
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma.多结节BCLC-A期肝细胞癌患者肝切除与经动脉化疗栓塞的疗效
J Liver Cancer. 2024 Sep;24(2):178-191. doi: 10.17998/jlc.2024.03.25. Epub 2024 Apr 3.
9
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center.中等规模中心内肝细胞癌超出巴塞罗那临床肝癌（BCLC）指征的手术治疗
J Visc Surg. 2018 Sep;155(4):275-282. doi: 10.1016/j.jviscsurg.2017.12.001. Epub 2018 Mar 29.
10
Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.优化BCLC B期肝细胞癌患者的管理：现代手术切除作为经动脉化疗栓塞的可行替代方案。
Eur J Surg Oncol. 2015 Sep;41(9):1153-61. doi: 10.1016/j.ejso.2015.05.023. Epub 2015 Jun 12.
本文引用的文献
1
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future.肝癌的新辅助和辅助系统治疗：现状与未来。
Hepatol Commun. 2024 Jun 3;8(6). doi: 10.1097/HC9.0000000000000430. eCollection 2024 Jun 1.
2
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma.多结节BCLC-A期肝细胞癌患者肝切除与经动脉化疗栓塞的疗效
J Liver Cancer. 2024 Sep;24(2):178-191. doi: 10.17998/jlc.2024.03.25. Epub 2024 Apr 3.
3
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives.肝细胞癌患者的多学科治疗方法：当前证据与未来展望
J Liver Cancer. 2024 Mar;24(1):47-56. doi: 10.17998/jlc.2024.02.27. Epub 2024 Mar 25.
4
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis.肝切除术与射频消融或经动脉化疗栓塞治疗早期（BCLC A）寡结节性肝细胞癌的比较：荟萃分析。
BJS Open. 2024 Jan 3;8(1). doi: 10.1093/bjsopen/zrad158.
5
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.《2022年韩国肝脏癌协会-韩国国立癌症中心肝细胞癌管理实践指南》
J Liver Cancer. 2023 Mar;23(1):1-120. doi: 10.17998/jlc.2022.11.07. Epub 2022 Dec 9.
6
Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors.肝细胞癌的组织病理学变异：根据世界卫生组织消化系统肿瘤分类第5版的更新
J Liver Cancer. 2020 Mar;20(1):17-24. doi: 10.17998/jlc.20.1.17. Epub 2020 Mar 31.
7
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
8
Tumor burden in patients with early and intermediate-stage hepatocellular carcinoma undergoing liver resection: a retrospective multicenter study on clinical and oncological outcomes.早期和中期肝细胞癌患者行肝切除术后的肿瘤负担：一项关于临床和肿瘤学结局的回顾性多中心研究。
HPB (Oxford). 2023 Jul;25(7):836-844. doi: 10.1016/j.hpb.2023.04.001. Epub 2023 Apr 9.
9
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?超出巴塞罗那临床肝癌分期（BCLC）标准的肝细胞癌肝切除术：多结节病变、门静脉高压和门静脉系统侵犯真的是禁忌证吗？
J Gastrointest Oncol. 2022 Dec;13(6):3123-3134. doi: 10.21037/jgo-22-833.
10
Long-term outcomes of living-donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3-cm nodules in a single institute.单中心中对具有三个<3cm结节的肝细胞癌进行活体肝移植、肝切除及局部治疗的长期结果
JGH Open. 2022 Jun 30;6(8):539-546. doi: 10.1002/jgh3.12783. eCollection 2022 Aug.
Zotero 插件